E Paietta

Summary

Country: USA

Publications

  1. ncbi Rare adult acute lymphocytic leukemia with CD56 expression in the ECOG experience shows unexpected phenotypic and genotypic heterogeneity
    E Paietta
    Our Lady of Mercy Cancer Center, New York Medical College, Bronx, New York 10466, USA
    Am J Hematol 66:189-96. 2001
  2. ncbi A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes
    E Paietta
    Immunology Laboratory, Our Lady of Mercy Cancer Center, New York Medical College, Bronx, New York 10466, USA
    Cytometry B Clin Cytom 59:1-9. 2004
  3. ncbi Low expression of the myeloid differentiation antigen CD65s, a feature of poorly differentiated AML in older adults: study of 711 patients enrolled in ECOG trials
    E Paietta
    Our Lady of Mercy Cancer Center, New York Medical College, Bronx, NY 10466, USA
    Leukemia 17:1544-50. 2003
  4. ncbi Phase II study of theophylline in chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E4998)
    P H Wiernik
    Our Lady of Mercy Cancer Center, New York Medical College, Bronx, NY 10466, USA
    Leukemia 18:1605-10. 2004
  5. ncbi Anticipation in familial chronic lymphocytic leukaemia
    P H Wiernik
    Comprehensive Cancer Center, Our Lady of Mercy Medical Center, New York Medical College, Bronx, NY 10466, USA
    Br J Haematol 113:407-14. 2001
  6. ncbi Acute promyelocytic leukemia cell line AP-1060 established as a cytokine-dependent culture from a patient clinically resistant to all-trans retinoic acid and arsenic trioxide
    Y Sun
    Department of Oncology, Montefiore Medical Center, Bronx, NY, USA
    Leukemia 18:1258-69. 2004

Detail Information

Publications6

  1. ncbi Rare adult acute lymphocytic leukemia with CD56 expression in the ECOG experience shows unexpected phenotypic and genotypic heterogeneity
    E Paietta
    Our Lady of Mercy Cancer Center, New York Medical College, Bronx, New York 10466, USA
    Am J Hematol 66:189-96. 2001
    ..Epstein-Barr virus (EBV) sequences were detected in one T- and both B-lymphoid cases. Our data suggest that CD56 is expressed at a precursor stage common to the T- and the B-cell lineage...
  2. ncbi A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes
    E Paietta
    Immunology Laboratory, Our Lady of Mercy Cancer Center, New York Medical College, Bronx, New York 10466, USA
    Cytometry B Clin Cytom 59:1-9. 2004
    ....
  3. ncbi Low expression of the myeloid differentiation antigen CD65s, a feature of poorly differentiated AML in older adults: study of 711 patients enrolled in ECOG trials
    E Paietta
    Our Lady of Mercy Cancer Center, New York Medical College, Bronx, NY 10466, USA
    Leukemia 17:1544-50. 2003
    ..Although not statistically significant, the observed association between low CD65s expression and decreased CR rate only in patients over the age of 55 is intriguing...
  4. ncbi Phase II study of theophylline in chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E4998)
    P H Wiernik
    Our Lady of Mercy Cancer Center, New York Medical College, Bronx, NY 10466, USA
    Leukemia 18:1605-10. 2004
    ..025). This suggests that in a CLL population treated with theophylline, induction of an apoptotic response to the drug in vitro is prognostic for absence of clinical progression...
  5. ncbi Anticipation in familial chronic lymphocytic leukaemia
    P H Wiernik
    Comprehensive Cancer Center, Our Lady of Mercy Medical Center, New York Medical College, Bronx, NY 10466, USA
    Br J Haematol 113:407-14. 2001
    ..A significant difference was observed between the ages of onset of the child generation and the SEER population (P < 0.00001), but not between the parent generation and the SEER population. Anticipation characterizes familial CLL...
  6. ncbi Acute promyelocytic leukemia cell line AP-1060 established as a cytokine-dependent culture from a patient clinically resistant to all-trans retinoic acid and arsenic trioxide
    Y Sun
    Department of Oncology, Montefiore Medical Center, Bronx, NY, USA
    Leukemia 18:1258-69. 2004
    ..25 microM ATO stimulated limited atypical maturation. These findings suggest that AP-1060 will be useful for further assessing molecular elements involved in APL progression and drug response/resistance...